A comprehensive genomic study of 390 H3F3A‑mutant pediatric and adult difuse high‑grade gliomas, CNS WHO grade 4 [PDF]
Malignant brain tumors, known as H3K27-altered diffuse midline glioma (DMG) and H3G34-mutant diffuse hemispheric glioma (DHG), can affect individuals of all ages and are classified as CNS WHO grade 4.
Brastianos, Priscilla K. +7 more
core +2 more sources
DIPG-64. UNRAVELING H3K27M INTERACTIONS IN DIFFUSE MIDLINE GLIOMA
Abstract BACKGROUND Diffuse midline glioma (DMG) harboring the histone H3 K27M mutation, also known as diffuse intrinsic pontine glioma when it occurs in the pons, is a uniformly fatal pediatric brain tumor. We sought to better understand protein-protein interactions of the mutant histone in DMG.
Liapodimitri, Athanasia +6 more
openaire +1 more source
A pineal mass in a 39‐year‐old woman
Brain Pathology, Volume 35, Issue 5, September 2025.
Charlotte Paoli +5 more
wiley +1 more source
H3.1K27M-induced misregulation of the TONSOKU-H3.1 pathway causes genomic instability
The oncomutation lysine 27-to-methionine in histone H3 (H3K27M) is frequently identified in tumors of patients with diffuse midline glioma-H3K27 altered (DMG-H3K27a).
Wenxin Yuan +10 more
doaj +1 more source
Emerging roles of cancer-associated histone mutations in genomic instabilities
Epigenetic mechanisms often fuel the quick evolution of cancer cells from normal cells. Mutations or aberrant expressions in the enzymes of DNA methylation, histone post-translational modifications, and chromatin remodellers have been extensively ...
Priyanka Yadav +2 more
doaj +1 more source
Treatment Strategies in Diffuse Midline Gliomas With the H3K27M Mutation: The Role of Convection-Enhanced Delivery in Overcoming Anatomic Challenges [PDF]
Benjamin Himes +2 more
openalex +1 more source
EZHIP's role in diffuse midline glioma: echoes of oncohistones? [PDF]
The enhancer of zeste inhibitory protein (EZHIP) is typically expressed during germ cell development and has been classified as a cancer-testis antigen (CTA) in various cancers.
Cassim, A +3 more
core +1 more source
HGG-19. CLINICAL RESPONSE TO THE PDGFRA/KIT INHIBITOR AVAPRITINIB IN PEDIATRIC AND YOUNG ADULT HIGH-GRADE GLIOMA PATIENTS WITH H3K27M OR PDGFRA GENOMIC ALTERATIONS [PDF]
Maria Trissal +49 more
openalex +1 more source
H3K27M-mutant, hemispheric diffuse glioma in an adult patient with prolonged survival
Noel Chia +7 more
openalex +1 more source

